Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2010
08/05/2010US20100197798 Abuse-resistant amphetamine prodrugs
08/05/2010US20100197766 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and Uses Thereof in the Treatment of Cancer
08/05/2010US20100197764 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression
08/05/2010US20100197751 Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
08/05/2010US20100197647 Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
08/05/2010US20100197609 Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
08/05/2010US20100197608 Use of melanotrophin-potentiating factor as a therapeutic agent
08/05/2010US20100197607 Mucin hypersecretion inhibitors and methods of use
08/05/2010US20100197606 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of the aids virus
08/05/2010US20100197605 Therapeutic use of peptide yglf and combination with kvlpvpq
08/05/2010US20100197604 Use of peptide as a therapeutic agent
08/05/2010US20100197603 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
08/05/2010US20100197602 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection
08/05/2010US20100197601 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection
08/05/2010US20100197600 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent
08/05/2010US20100197599 Use of a peptide as a therapeutic agent
08/05/2010US20100197598 Novel macromolecule transduction domains and methods for identification and uses thereof
08/05/2010US20100197597 Coagulation Factor VII Polypeptides
08/05/2010US20100197596 Compositions and methods for diagnosis and treatment of type 2 diabetes
08/05/2010US20100197595 Treatment of melanoma with alpha thymosin peptides
08/05/2010US20100197593 Modulators of the ABC Transporter Family and Methods for their Use
08/05/2010US20100197591 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES
08/05/2010US20100197590 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES
08/05/2010US20100197589 Modified growth hormone polypeptides
08/05/2010US20100197588 Use of a peptide as a therapeutic agent
08/05/2010US20100197587 Use of a peptide as a therapeutic agent
08/05/2010US20100197586 Use of secretin and optionally urodilatin as therapeutic agents
08/05/2010US20100197585 Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agent
08/05/2010US20100197584 Use of curcumin to block brain tumor formation in mice
08/05/2010US20100197583 Glycosaminoglycan-antagonising MCP-1 Mutants and Methods of Using Same
08/05/2010US20100197582 Growth hormone fusion proteins
08/05/2010US20100197581 Native gp41 assay
08/05/2010US20100197580 Parstatin peptides and uses thereof
08/05/2010US20100197579 Corticotropin Releasing Factor 2 Receptor Agonists
08/05/2010US20100197578 Demannosylated recombinant factor viii [[vii]] for the treatment of patients with haemophilia a
08/05/2010US20100197577 Nitric oxide synthase activator
08/05/2010US20100197576 Polypeptides or fusion proteins thereof inhibiting transmigration of leucocytes or growth and/or metastasis of cancer cells
08/05/2010US20100197575 Soluble interleukin-20 receptor
08/05/2010US20100197574 Aquaretic and natriuretic polypeptides lacking vasodilatory activity
08/05/2010US20100197573 Transglutaminase Mediated Conjugation of Growth Hormone
08/05/2010US20100197572 Use of somatostatin-14 as a therapeutic agent
08/05/2010US20100197571 Extrudates with improved taste masking
08/05/2010US20100197570 Cyclodepsipeptides with Antineoplastic Activity and Methods of Using to Inhibit Cancer and Microbial Growth
08/05/2010US20100197569 Cross-linked glycopeptide-cephalosporin antibiotics
08/05/2010US20100197568 Protective hydrocolloid for active ingredients
08/05/2010US20100197567 Conus polypeptides
08/05/2010US20100197566 Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute
08/05/2010US20100197565 Dry powder drug delivery system
08/05/2010US20100197564 Diaryl morpholines as cb1 modulators
08/05/2010US20100197563 Compositions and methods for altering elastogenesis
08/05/2010US20100197562 Functionally selective alpha2c adrenoreceptor agonists
08/05/2010US20100197561 Biomarkers for Ovarian Cancer: B2 Microglobulin
08/05/2010US20100196998 System and method for electroporating a sample
08/05/2010US20100196988 Bioreactive Agents
08/05/2010US20100196962 Il-6 receptor il-6 direct fusion protein
08/05/2010US20100196524 Novel peptides and methods for producing them
08/05/2010US20100196493 Method for producing stable powder compositions
08/05/2010US20100196492 Electrostatic coating of particles for drug delivery
08/05/2010US20100196489 Bone growth particles and osteoinductive composition thereof
08/05/2010US20100196478 Protein matrix materials, devices and methods of making and using thereof
08/05/2010US20100196477 Dry Mouldable drug formulation
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196458 Modified cytokines for use in cancer therapy
08/05/2010US20100196456 Emulsion preconcentrates and micellar formulations containing wood resins
08/05/2010US20100196454 Dressing formulations to prevent and reduce scarring
08/05/2010US20100196453 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
08/05/2010US20100196452 Pharmaceutical compositions and methods for treating erectile dysfunction
08/05/2010US20100196447 Silk biomaterials and methods of use thereof
08/05/2010US20100196445 Systems and methods for delivery of biologically active agents
08/05/2010US20100196441 Uses of immunologically modified scaffold for tissue prevascularization cell transplantation
08/05/2010US20100196440 Implant Material
08/05/2010US20100196439 Angiogenesis Mechanism and Method, and Implantable Device
08/05/2010US20100196438 Methods including medical devices having a surface including a biologically active agent therein
08/05/2010US20100196437 Medical devices having a surface including a biologically active agent therein
08/05/2010US20100196435 Materials and methods for delivering compositions to selected tissues
08/05/2010US20100196434 Combined fibnrinolytic and antimicrobial cathether and uses thetherof
08/05/2010US20100196433 Prevascularized devices and related methods
08/05/2010US20100196423 soluble neutral active Hyaluronidase Glycoproteins (sHASEGPs); use treating glycosaminoglycan associated pathologies such as tumors or eye disorders; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes
08/05/2010US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS
08/05/2010US20100196410 Streptococcus pneumoniae Antigens and Vaccines
08/05/2010US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof
08/05/2010US20100196407 Tick galectin
08/05/2010US20100196406 Agents for the treatment of inflammatory diseases and methods of using same
08/05/2010US20100196400 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196397 Five-helix protein
08/05/2010US20100196396 Compositions and methods for modulating ghrelin-mediated conditions
08/05/2010US20100196393 Modulation of blood brain barrier protein expression
08/05/2010US20100196389 Methods of using corticotropin-releasing factor for the use of the treatment of cancer
08/05/2010US20100196387 Disulfide, Sulfide, Sulfoxide, and Sulfone Derivatives of Cyclic Sugars and Uses Thereof
08/05/2010US20100196386 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
08/05/2010US20100196383 Connective Tissue Growth Factor (CTGF-3)
08/05/2010US20100196382 Nontypeable Haemophilus Influenzae Virulence Factors
08/05/2010US20100196381 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
08/05/2010US20100196378 Removal promoters and inhibitor for apoptosis cells in vivo
08/05/2010US20100196376 Method for reducing allergen-induced airway hyperresponsiveness
08/05/2010US20100196372 FcgammaRIIB Fusion Proteins and Compositions Thereof
08/05/2010US20100196369 Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
08/05/2010US20100196360 Neutrokine-alpha and neutrokine-alpha splice variant
08/05/2010US20100196353 Intradermal hpv peptide vaccination
1 ... 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 ... 3163